[go: up one dir, main page]

AU7630694A - Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor - Google Patents

Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor

Info

Publication number
AU7630694A
AU7630694A AU76306/94A AU7630694A AU7630694A AU 7630694 A AU7630694 A AU 7630694A AU 76306/94 A AU76306/94 A AU 76306/94A AU 7630694 A AU7630694 A AU 7630694A AU 7630694 A AU7630694 A AU 7630694A
Authority
AU
Australia
Prior art keywords
cystic fibrosis
antibodies specific
fibrosis transmembrane
conductance regulator
transmembrane conductance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76306/94A
Inventor
Seng H Cheng
Richard Gregory
John Marshall
Patrick W Rafter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of AU7630694A publication Critical patent/AU7630694A/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4712—Cystic fibrosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU76306/94A 1993-08-27 1994-08-08 Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor Abandoned AU7630694A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US114950 1980-01-23
US11495093A 1993-08-27 1993-08-27
PCT/US1994/008970 WO1995006066A1 (en) 1993-08-27 1994-08-08 Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor

Publications (1)

Publication Number Publication Date
AU7630694A true AU7630694A (en) 1995-03-21

Family

ID=22358436

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76306/94A Abandoned AU7630694A (en) 1993-08-27 1994-08-08 Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor

Country Status (2)

Country Link
AU (1) AU7630694A (en)
WO (1) WO1995006066A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240846A (en) * 1989-08-22 1993-08-31 The Regents Of The University Of Michigan Gene therapy vector for cystic fibrosis

Also Published As

Publication number Publication date
WO1995006066A1 (en) 1995-03-02

Similar Documents

Publication Publication Date Title
AU3628795A (en) Accelerator-base methods and apparatus for measurement-while-drilling
AU5950196A (en) Gas-permeable membrane
AU7331796A (en) Knapsack
AU7472196A (en) Alpha-helix mimetics and methods relating thereto
AU5885296A (en) Electrochemical apparatus and process
EP0801337A3 (en) Toner bottle and toner supplying apparatus using the same
AU6146596A (en) Lower-energy hydrogen methods and structures
AU7663596A (en) Materials and methods for controlling nematodes
AU675398B2 (en) Quantitative charging apparatus
AU5051296A (en) Quantitative charging apparatus
AU4062195A (en) Monolayer curl-salting process and apparatus
AU7422496A (en) NM03 antibody materials and methods
AU5058098A (en) Prediction method and device with motion compensation
AU5315796A (en) Mammalian expression vectors
AU7633596A (en) Control methods and apparatus
AU7138196A (en) Material analysis
AU3489193A (en) Cystic fibrosis transmembrane conductance regulator (CFTR) protein
AU6015196A (en) Voltage regulator
AU1373395A (en) Vpr receptor protein
AU6975996A (en) Stabilized agchemical concentrate and use thereof
AU6529494A (en) Electrographic element and process
AU7630694A (en) Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor
AU6259296A (en) Carbamazepine hydrazides useful in immunoassays
AU5939896A (en) Serum immunoregulatory polypeptides and uses therefor
AU5132996A (en) Codominance-mediated toxins